Tuesday May 8 | Freshnews
PharmAthene Reports First Quarter 2012 Financial Results
ANNAPOLIS, Md., May 8, 2012 /PRNewswire/ -- PharmAthene, Inc. , a biodefense company developing medical countermeasures against biological and chemical threats, today reported its financial results for the first quarter ended March 31, 2012.
GE Capital Closes $7.5 Million in Senior Secured Facilities for PharmAthene
BETHESDA, Md. -- -- GE Capital, Healthcare Financial Services announced today that it was sole lender and administrative agent on $7.5 million in senior secured credit facilities for PharmAthene, consisting of a $2.5 million term loan and a $5 million revolving line of credit.
GE Capital provides $7.5M in senior secured credit facilities to PharmAthene
GE Capital, Healthcare Financial Services announced today that it was sole lender and administrative agent on $7.5 million in senior secured credit facilities for PharmAthene, consisting of a $2.5 million term loan and a $5 million revolving line of credit.